| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319eed6d6813db49e8057bdaa5e60233 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-28 |
| filingDate |
2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91340286c8d969ab7586cff9bf0f7719
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d1a553b02c73208b9de30e0f5b19f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb6ab5493912e18b5d05867eb1afb93 |
| publicationDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011117589-A1 |
| titleOfInvention |
Use of procalcitonin (pct) in prognosis following acute coronary syndromes |
| abstract |
Subject of the present invention are assays and in vitro methods for determining a prognosis for a patient having an acute coronary syndrome, whereby the level of procalcitonin or fragments thereof is measured in a sample obtained from said patient. Said level of procalcitonin or fragments thereof may then be correlated to a predisposition to an adverse outcome of said acute coronary syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9488659-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9753039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11143659-B2 |
| priorityDate |
2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |